Data-driven establishment of morphology-based diagnosis of Sézary Syndrome by means of imaging flow cytometry.
Early diagnosis of cancer is a key determinant of patient outcome. Hematological malignancies manifest themselves in the blood and are therefore amenable to blood-based diagnostics. Traditionally, such diagnostic procedures rely on manual expert microscopical evaluation of blood cell morphology and suffer from subjectivity, limited throughput and low sensitivity.